Scarica l'app Stockscreener
14.58
0.82%
-0.12
Pre-mercato:
13.81
-0.77
-5.28%
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Granahan Investment Management LLC Has $8.01 Million Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Braidwell LP Has $62.27 Million Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Bamco Inc. NY Buys Shares of 60,000 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Deep Track Capital LP Sells 390,115 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Learn to Evaluate (EWTX) using the Charts - news.stocktradersdaily.com
Algert Global LLC Has $2.94 Million Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Cubist Systematic Strategies LLC Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by DAFNA Capital Management LLC - MarketBeat
Driehaus Capital Management LLC Has $39.88 Million Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Bought by Deerfield Management Company L.P. Series C - MarketBeat
Edgewise Therapeutics Reports Strong Q1 2025 Progress - TipRanks
Wedbush Adjusts Price Target on Edgewise Therapeutics to $40 From $43, Maintains Outperform Rating - marketscreener.com
Edgewise Therapeutics shares fall on in-line Q1 results By Investing.com - Investing.com India
EDGEWISE THERAPEUTICS Earnings Results: $EWTX Reports Quarterly Earnings - Nasdaq
Edgewise Therapeutics, Inc. SEC 10-Q Report - TradingView
Edgewise Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Baker BROS. Advisors LP - MarketBeat
Schonfeld Strategic Advisors LLC Reduces Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView
Ally Bridge Group NY LLC Sells 104,519 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Acuta Capital Partners LLC Buys 24,658 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Invesco Ltd. Sells 21,341 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (EWTX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Envestnet Asset Management Inc. - Defense World
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is Novo Holdings A S's 4th Largest Position - MarketBeat
Marshall Wace LLP Has $798,000 Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Now Covered by Guggenheim - MarketBeat
Voya Investment Management LLC Lowers Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Is Edgewise Therapeutics, Inc. (EWTX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Adage Capital Partners GP L.L.C. Purchases 218,491 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Foresite Capital Management VI LLC Buys New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey
First Light Asset Management LLC Purchases Shares of 780,639 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Why Edgewise Therapeutics Stock Popped This Week - The Globe and Mail
Edgewise Therapeutics (EWTX) Initiated at Buy by Guggenheim, Pot - GuruFocus
Edgewise a new buy at Guggenheim on two pipeline prospects - Seeking Alpha
Edgewise Therapeutics (EWTX) Receives Positive Coverage with Str - GuruFocus
Guggenheim Starts Edgewise Therapeutics With Buy Rating, $41 Price Target - marketscreener.com
79,381 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Harvest Investment Services LLC - MarketBeat
JPMorgan Chase & Co. Sells 34,071 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Russell Investments Group Ltd. Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics' (EWTX) Outperform Rating Reaffirmed at Wedbush - MarketBeat
0.84%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):